Published in J Biol Chem on November 09, 2009
Guidance molecules in axon regeneration. Cold Spring Harb Perspect Biol (2010) 1.55
Niacin treatment of stroke increases synaptic plasticity and axon growth in rats. Stroke (2010) 1.07
Sensory axon regeneration: rebuilding functional connections in the spinal cord. Trends Neurosci (2011) 1.03
Neuronal Nogo-A regulates glutamate receptor subunit expression in hippocampal neurons. J Neurochem (2011) 0.93
Prevention of diabetic neuropathy by regulatable expression of HSV-mediated erythropoietin. Mol Ther (2010) 0.90
Hippocampal expression of myelin-associated inhibitors is induced with age-related cognitive decline and correlates with deficits of spatial learning and memory. J Neurochem (2012) 0.88
Reduction of voltage gated sodium channel protein in DRG by vector mediated miRNA reduces pain in rats with painful diabetic neuropathy. Mol Pain (2012) 0.84
Rho GTPase regulation of α-synuclein and VMAT2: implications for pathogenesis of Parkinson's disease. Mol Cell Neurosci (2011) 0.83
Gray matter is targeted in first-attack multiple sclerosis. PLoS One (2013) 0.82
HSV-mediated gene transfer of C3 transferase inhibits Rho to promote axonal regeneration. Exp Neurol (2012) 0.81
HspB1 silences translation of PDZ-RhoGEF by enhancing miR-20a and miR-128 expression to promote neurite extension. Mol Cell Neurosci (2013) 0.76
Multiple uses of fibrin sealant for nervous system treatment following injury and disease. J Venom Anim Toxins Incl Trop Dis (2017) 0.76
Methylprednisolone inhibits Nogo-A protein expression after acute spinal cord injury. Neural Regen Res (2013) 0.75
Expressing Constitutively Active Rheb in Adult Dorsal Root Ganglion Neurons Enhances the Integration of Sensory Axons that Regenerate Across a Chondroitinase-Treated Dorsal Root Entry Zone Following Dorsal Root Crush. Front Mol Neurosci (2016) 0.75
NT-3 promotes proprioceptive axon regeneration when combined with activation of the mTor intrinsic growth pathway but not with reduction of myelin extrinsic inhibitors. Exp Neurol (2016) 0.75
Rgulatable Transgene Expression for Prevention of Chemotherapy-Induced Peripheral Neuropathy. Mol Ther Methods Clin Dev (2017) 0.75
Regulatable Transgene Expression for Prevention of Chemotherapy-Induced Peripheral Neuropathy. Mol Ther Methods Clin Dev (2017) 0.75
A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain (1988) 18.17
Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature (2000) 5.22
Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration. Nature (2001) 4.96
Myelin-associated inhibitors of axonal regeneration in the adult mammalian CNS. Nat Rev Neurosci (2003) 4.60
Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein. Nature (2000) 4.30
Axon regeneration in young adult mice lacking Nogo-A/B. Neuron (2003) 4.23
Myelination in rat brain: method of myelin isolation. J Neurochem (1973) 4.01
Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth. Nature (2002) 3.81
CRMP-2 binds to tubulin heterodimers to promote microtubule assembly. Nat Cell Biol (2002) 3.71
Nogo-66 receptor antagonist peptide promotes axonal regeneration. Nature (2002) 3.33
P75 interacts with the Nogo receptor as a co-receptor for Nogo, MAG and OMgp. Nature (2002) 3.27
LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex. Nat Neurosci (2004) 3.24
Lack of enhanced spinal regeneration in Nogo-deficient mice. Neuron (2003) 3.22
Axonal regeneration in the rat spinal cord produced by an antibody against myelin-associated neurite growth inhibitors. Nature (1990) 3.22
Inhibitor of neurite outgrowth in humans. Nature (2000) 2.89
Rho kinase inhibition enhances axonal regeneration in the injured CNS. J Neurosci (2003) 2.76
TAJ/TROY, an orphan TNF receptor family member, binds Nogo-66 receptor 1 and regulates axonal regeneration. Neuron (2005) 2.39
Systemic deletion of the myelin-associated outgrowth inhibitor Nogo-A improves regenerative and plastic responses after spinal cord injury. Neuron (2003) 2.32
Blockade of Nogo-66, myelin-associated glycoprotein, and oligodendrocyte myelin glycoprotein by soluble Nogo-66 receptor promotes axonal sprouting and recovery after spinal injury. J Neurosci (2004) 2.29
Serine phosphorylation negatively regulates RhoA in vivo. J Biol Chem (2003) 2.28
Genetic deletion of the Nogo receptor does not reduce neurite inhibition in vitro or promote corticospinal tract regeneration in vivo. Proc Natl Acad Sci U S A (2005) 2.27
Patterns of Nogo mRNA and protein expression in the developing and adult rat and after CNS lesions. J Neurosci (2002) 2.27
Delayed systemic Nogo-66 receptor antagonist promotes recovery from spinal cord injury. J Neurosci (2003) 2.23
Nogo-A antibody improves regeneration and locomotion of spinal cord-injured rats. Ann Neurol (2005) 2.22
Prior exposure to neurotrophins blocks inhibition of axonal regeneration by MAG and myelin via a cAMP-dependent mechanism. Neuron (1999) 2.16
The Nogo-66 receptor homolog NgR2 is a sialic acid-dependent receptor selective for myelin-associated glycoprotein. J Neurosci (2005) 1.93
Arginase I and polyamines act downstream from cyclic AMP in overcoming inhibition of axonal growth MAG and myelin in vitro. Neuron (2002) 1.86
Phosphorylation of collapsin response mediator protein-2 by Rho-kinase. Evidence for two separate signaling pathways for growth cone collapse. J Biol Chem (2000) 1.73
HSV-mediated gene transfer of vascular endothelial growth factor to dorsal root ganglia prevents diabetic neuropathy. Gene Ther (2005) 1.63
Nogo-A, -B, and -C are found on the cell surface and interact together in many different cell types. J Biol Chem (2005) 1.61
Synaptic function for the Nogo-66 receptor NgR1: regulation of dendritic spine morphology and activity-dependent synaptic strength. J Neurosci (2008) 1.60
Phosphorylation by Rho kinase regulates CRMP-2 activity in growth cones. Mol Cell Biol (2005) 1.56
Peripherally delivered glutamic acid decarboxylase gene therapy for spinal cord injury pain. Mol Ther (2004) 1.56
Persistent restoration of sensory function by immediate or delayed systemic artemin after dorsal root injury. Nat Neurosci (2008) 1.47
Locomotor recovery in spinal cord-injured rats treated with an antibody neutralizing the myelin-associated neurite growth inhibitor Nogo-A. J Neurosci (2001) 1.46
Transgenic inhibition of Nogo-66 receptor function allows axonal sprouting and improved locomotion after spinal injury. Mol Cell Neurosci (2005) 1.43
Rho-modifying C3-like ADP-ribosyltransferases. Rev Physiol Biochem Pharmacol (2004) 1.43
Tumor necrosis factor-alpha contributes to below-level neuropathic pain after spinal cord injury. Ann Neurol (2006) 1.43
Nogo-receptor gene activity: cellular localization and developmental regulation of mRNA in mice and humans. J Comp Neurol (2002) 1.40
HSV-mediated transfer of interleukin-10 reduces inflammatory pain through modulation of membrane tumor necrosis factor alpha in spinal cord microglia. Gene Ther (2007) 1.22
Repulsive factors and axon regeneration in the CNS. Curr Opin Neurobiol (2001) 1.19
Protein kinase A-mediated phosphorylation of the Galpha13 switch I region alters the Galphabetagamma13-G protein-coupled receptor complex and inhibits Rho activation. J Biol Chem (2002) 1.18
Anti-Nogo-A antibody treatment enhances sprouting of corticospinal axons rostral to a unilateral cervical spinal cord lesion in adult macaque monkey. J Comp Neurol (2007) 1.17
Synaptic destabilization by neuronal Nogo-A. Brain Cell Biol (2007) 1.17
Herpes simplex virus 1-mediated transfer of preproenkephalin A in rat dorsal root ganglia. J Neurochem (1998) 1.14
Activated RHOA and peripheral axon regeneration. Exp Neurol (2008) 1.12
Phosphorylation of GTP dissociation inhibitor by PKA negatively regulates RhoA. Am J Physiol Cell Physiol (2008) 1.07
Myosin IIA is required for neurite outgrowth inhibition produced by repulsive guidance molecule. J Neurochem (2007) 1.06
Neuronal Nogo-A modulates growth cone motility via Rho-GTP/LIMK1/cofilin in the unlesioned adult nervous system. J Biol Chem (2009) 1.06
Myelin-associated glycoprotein inhibits microtubule assembly by a Rho-kinase-dependent mechanism. J Biol Chem (2006) 1.06
Nogo-A expression in the intact and injured nervous system. Mol Cell Neurosci (2003) 1.05
Inactivation of intracellular Rho to stimulate axon growth and regeneration. Prog Brain Res (2002) 1.03
Neuronal responses to myelin are mediated by rho kinase. J Neurochem (2006) 1.03
Nogo-A expression after focal ischemic stroke in the adult rat. Stroke (2008) 0.99
Phosphorylation of the regulator of G protein signaling RGS9-1 by protein kinase A is a potential mechanism of light- and Ca2+-mediated regulation of G protein function in photoreceptors. Biochemistry (2001) 0.97
Selective temporal and regional alterations of Nogo-A and small proline-rich repeat protein 1A (SPRR1A) but not Nogo-66 receptor (NgR) occur following traumatic brain injury in the rat. Exp Neurol (2006) 0.95
Release of GABA from sensory neurons transduced with a GAD67-expressing vector occurs by non-vesicular mechanisms. Brain Res (2006) 0.94
A soluble Nogo receptor differentially affects plasticity of spinally projecting axons. Eur J Neurosci (2004) 0.90
Gene therapy: novel treatments for polyneuropathy and chronic pain. Curr Neurol Neurosci Rep (2004) 0.90
Nogo-A expressed in Schwann cells impairs axonal regeneration after peripheral nerve injury. J Cell Biol (2002) 0.89
Immunization with recombinant Nogo-66 receptor (NgR) promotes axonal regeneration and recovery of function after spinal cord injury in rats. Neurobiol Dis (2008) 0.89
Molecular analysis of Nogo expression in the hippocampus during development and following lesion and seizure. FASEB J (2003) 0.86
The differential expression patterns of messenger RNAs encoding Nogo-A and Nogo-receptor in the rat central nervous system. Brain Res Mol Brain Res (2005) 0.85
HSV-mediated transfer of artemin overcomes myelin inhibition to improve outcome after spinal cord injury. Mol Ther (2009) 0.82
Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism. Cell (2012) 7.36
PubChem's BioAssay Database. Nucleic Acids Res (2011) 3.74
Lkb1 regulates quiescence and metabolic homeostasis of haematopoietic stem cells. Nature (2010) 3.54
Stem cell therapy in a caprine model of osteoarthritis. Arthritis Rheum (2003) 3.39
Passenger deletions generate therapeutic vulnerabilities in cancer. Nature (2012) 3.11
DDB1 functions as a linker to recruit receptor WD40 proteins to CUL4-ROC1 ubiquitin ligases. Genes Dev (2006) 2.75
PLAGL2 regulates Wnt signaling to impede differentiation in neural stem cells and gliomas. Cancer Cell (2010) 2.68
Rechallenging with clozapine following neutropenia: treatment options for refractory schizophrenia. Am J Psychiatry (2008) 2.40
Impairment of cellulose synthases required for Arabidopsis secondary cell wall formation enhances disease resistance. Plant Cell (2007) 2.01
Telomerase reactivation following telomere dysfunction yields murine prostate tumors with bone metastases. Cell (2012) 1.75
In vivo gene therapy for pyridoxine-induced neuropathy by herpes simplex virus-mediated gene transfer of neurotrophin-3. Ann Neurol (2002) 1.74
Enhanced visual motion perception in major depressive disorder. J Neurosci (2009) 1.71
Structure-based virtual screening for drug discovery: a problem-centric review. AAPS J (2012) 1.68
miRNA-145 inhibits non-small cell lung cancer cell proliferation by targeting c-Myc. J Exp Clin Cancer Res (2010) 1.67
FoxOs enforce a progression checkpoint to constrain mTORC1-activated renal tumorigenesis. Cancer Cell (2010) 1.58
Peripherally delivered glutamic acid decarboxylase gene therapy for spinal cord injury pain. Mol Ther (2004) 1.56
Gene transfer of glutamic acid decarboxylase reduces neuropathic pain. Ann Neurol (2005) 1.47
Absence of gender disparity in short-term clinical outcomes in patients with acute ST-segment elevation myocardial infarction undergoing sirolimus-eluting stent based primary coronary intervention: a report from Shanghai Acute Coronary Event (SACE) Registry. Chin Med J (Engl) (2010) 1.44
Complete genome sequence of Aeromonas veronii strain B565. J Bacteriol (2011) 1.43
Tumor necrosis factor-alpha contributes to below-level neuropathic pain after spinal cord injury. Ann Neurol (2006) 1.43
Improved outcomes from transradial over transfemoral access in primary percutaneous coronary intervention for patients with acute ST-segment elevation myocardial infarction and upstream use of tirofiban. Chin Med J (Engl) (2013) 1.42
Efficacy and safety of aliskiren, a direct renin inhibitor, compared with ramipril in Asian patients with mild to moderate hypertension. Hypertens Res (2011) 1.42
Prospective multicenter randomized trial comparing physician versus patient transfer for primary percutaneous coronary intervention in acute ST-segment elevation myocardial infarction. Chin Med J (Engl) (2008) 1.40
Herpes vector-mediated expression of proenkephalin reduces bone cancer pain. Ann Neurol (2002) 1.40
Mig-6 controls EGFR trafficking and suppresses gliomagenesis. Proc Natl Acad Sci U S A (2010) 1.38
STAR RNA-binding protein Quaking suppresses cancer via stabilization of specific miRNA. Genes Dev (2012) 1.38
HSV-mediated expression of interleukin-4 in dorsal root ganglion neurons reduces neuropathic pain. Mol Pain (2006) 1.32
Design, synthesis, and preclinical evaluation of prostate-specific membrane antigen targeted (99m)Tc-radioimaging agents. Mol Pharm (2009) 1.31
Gene therapy for pain: results of a phase I clinical trial. Ann Neurol (2011) 1.31
Design, synthesis, and biological evaluation of antiviral agents targeting flavivirus envelope proteins. J Med Chem (2008) 1.28
Value of serum glycated albumin and high-sensitivity C-reactive protein levels in the prediction of presence of coronary artery disease in patients with type 2 diabetes. Cardiovasc Diabetol (2006) 1.25
Progress in gene therapy for neurological disorders. Nat Rev Neurol (2013) 1.22
Herpes vector-mediated gene transfer in treatment of diseases of the nervous system. Annu Rev Microbiol (2004) 1.21
Erythropoietin protects CA1 neurons against global cerebral ischemia in rat: potential signaling mechanisms. J Neurosci Res (2006) 1.20
Transcriptome analysis of the model protozoan, Tetrahymena thermophila, using Deep RNA sequencing. PLoS One (2012) 1.19
Herpes vector-mediated gene transfer in the treatment of chronic pain. Mol Ther (2008) 1.17
Addison's disease due to adrenal tuberculosis: contrast-enhanced CT features and clinical duration correlation. Eur J Radiol (2006) 1.17
IL-10 promotes neuronal survival following spinal cord injury. Exp Neurol (2009) 1.16
Lipid bilayers: an essential environment for the understanding of membrane proteins. Magn Reson Chem (2007) 1.16
Glial TNFα in the spinal cord regulates neuropathic pain induced by HIV gp120 application in rats. Mol Pain (2011) 1.15
Humanizing murine IgG3 anti-GD2 antibody m3F8 substantially improves antibody-dependent cell-mediated cytotoxicity while retaining targeting in vivo. Oncoimmunology (2012) 1.14
Herpes simplex-mediated gene transfer of nerve growth factor protects against peripheral neuropathy in streptozotocin-induced diabetes in the mouse. Diabetes (2002) 1.14
Interleukin-10 provides direct trophic support to neurons. J Neurochem (2009) 1.14
Engineering an endomorphin-2 gene for use in neuropathic pain therapy. Pain (2007) 1.13
Screening for significant atherosclerotic renal artery stenosis with a regression model in patients undergoing transradial coronary angiography/intervention. J Zhejiang Univ Sci B (2012) 1.13
Continuous delta-opioid receptor activation reduces neuronal voltage-gated sodium channel (NaV1.7) levels through activation of protein kinase C in painful diabetic neuropathy. J Neurosci (2008) 1.13
Reduced ventral striatal/ventral pallidal serotonin1B receptor binding potential in major depressive disorder. Psychopharmacology (Berl) (2010) 1.13
Construction of a series of vectors for high throughput cloning and expression screening of membrane proteins from Mycobacterium tuberculosis. BMC Biotechnol (2008) 1.12
Knowledge, awareness, behavior (KAB) and control of hypertension among urban elderly in western China. Int J Cardiol (2008) 1.10
Clone DB: an integrated NCBI resource for clone-associated data. Nucleic Acids Res (2012) 1.09
STK39 is an independent risk factor for male hypertension in Han Chinese. Int J Cardiol (2010) 1.07
HSV-mediated gene transfer of the glial cell-derived neurotrophic factor provides an antiallodynic effect on neuropathic pain. Mol Ther (2003) 1.07
Effects of transgene-mediated endomorphin-2 in inflammatory pain. Eur J Pain (2008) 1.06
Protective effect of herpes simplex virus-mediated neurotrophin gene transfer in cisplatin neuropathy. Brain (2004) 1.04
Applications of gene therapy to the treatment of chronic pain. Curr Gene Ther (2008) 1.03
Caffeine prevents protection in two human models of ischemic preconditioning. J Am Coll Cardiol (2006) 1.03
Role of the SaeRS two-component regulatory system in Staphylococcus epidermidis autolysis and biofilm formation. BMC Microbiol (2011) 1.02
The relationship of herpes simplex virus latency associated transcript expression to genome copy number: a quantitative study using laser capture microdissection. J Neurovirol (2002) 1.01
Increased serum glycated albumin level is associated with the presence and severity of coronary artery disease in type 2 diabetic patients. Circ J (2007) 1.01
The class A chitin synthase gene of Spodoptera exigua: molecular cloning and expression patterns. Insect Biochem Mol Biol (2007) 1.01
Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1/Th2 cytokine profiles in patients with Kawasaki disease. Arthritis Rheum (2013) 1.01
Synthesis and anti-HIV activity of new alkenyldiarylmethane (ADAM) non-nucleoside reverse transcriptase inhibitors (NNRTIs) incorporating benzoxazolone and benzisoxazole rings. Bioorg Med Chem (2006) 0.99
High-level expression of the recombinant hybrid peptide cecropinA(1-8)-magainin2(1-12) with an ubiquitin fusion partner in Escherichia coli. Protein Expr Purif (2007) 0.97
Neuroprotective effect of herpes simplex virus-mediated gene transfer of erythropoietin in hyperglycemic dorsal root ganglion neurons. Brain (2009) 0.97
High yield expression of an AHL-lactonase from Bacillus sp. B546 in Pichia pastoris and its application to reduce Aeromonas hydrophila mortality in aquaculture. Microb Cell Fact (2010) 0.97
Orally administered thermostable N-acyl homoserine lactonase from Bacillus sp. strain AI96 attenuates Aeromonas hydrophila infection in zebrafish. Appl Environ Microbiol (2012) 0.97
A novel cell-cell signaling by microglial transmembrane TNFα with implications for neuropathic pain. Pain (2010) 0.97
Reduced amygdala serotonin transporter binding in posttraumatic stress disorder. Biol Psychiatry (2011) 0.96
Isolated Anxa5+/Sca-1+ perivascular cells from mouse meningeal vasculature retain their perivascular phenotype in vitro and in vivo. Exp Cell Res (2007) 0.96
Molecular and biochemical characterization of a novel xylanase from the symbiotic Sphingobacterium sp. TN19. Appl Microbiol Biotechnol (2009) 0.96
Decreased serum esRAGE level is associated with angiographically determined coronary plaque progression in diabetic patients. Clin Biochem (2009) 0.96
The apoptosis-associated protein BNIPL interacts with two cell proliferation-related proteins, MIF and GFER. FEBS Lett (2003) 0.96
Dissociation of an antiviral compound from the internal pocket of human rhinovirus 14 capsid. Proc Natl Acad Sci U S A (2005) 0.96
Impact of the Staphylococcus epidermidis LytSR two-component regulatory system on murein hydrolase activity, pyruvate utilization and global transcriptional profile. BMC Microbiol (2010) 0.96
Long-term neuroprotection achieved with latency-associated promoter-driven herpes simplex virus gene transfer to the peripheral nervous system. Mol Ther (2005) 0.96
Characterization and expression patterns of a membrane-bound trehalase from Spodoptera exigua. BMC Mol Biol (2008) 0.96
MiR-200b expression in breast cancer: a prognostic marker and act on cell proliferation and apoptosis by targeting Sp1. J Cell Mol Med (2015) 0.96
Reversible transdifferentiation of blood vascular endothelial cells to a lymphatic-like phenotype in vitro. J Cell Sci (2010) 0.95